• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WU Yiling, YOU Qi, WU Jie. Therapeutic effect of oral vaccine based on glutamate decarboxylase 65 on streptozotocin-induced type 1 diabetic mice[J]. Journal of China Pharmaceutical University, 2021, 52(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20210515
Citation: WU Yiling, YOU Qi, WU Jie. Therapeutic effect of oral vaccine based on glutamate decarboxylase 65 on streptozotocin-induced type 1 diabetic mice[J]. Journal of China Pharmaceutical University, 2021, 52(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20210515
shu

Therapeutic effect of oral vaccine based on glutamate decarboxylase 65 on streptozotocin-induced type 1 diabetic mice

  • School of Life Science and Technology, China Pharmaceutical University,Nanjing 211198, China

More Information
  • Received Date: March 23, 2021
  • Revised Date: May 16, 2021
    Graphical Abstract
    • Abstract
  • To investigate the therapeutic effect of oral vaccine based on glutamate decarboxylase 65 (GAD65) on streptozotocin (STZ) -induced type 1 diabetic (T1D) mice, the mice model of T1D was established by intraperitoneal injection of low dose multiple STZ. CTB-GADIII encapsulated with calcium alginate (Ca-Alg-GADIII) was formulated using crosslinking technology with sodium alginate and calcium chloride, and was administered intragastric to T1D mice once a week for 5 consecutive weeks.Blood glucose and body weight of the mice were recorded weekly, and pharmacodynamics against T1D of Ca-Alg-GADIII were investigated by glucose tolerance assay (OGTT) and pancreatic histopathological analysis. The levels of glutamic acid decarboxylase antibody (GADA), and insulin autoantibody (IAA) and related cytokines (IL-4, IFN-γ, TGF-β1) in serum were detected by ELISA, and the CD4 + T cell subsets were detected by flow cytometry. The immunological mechanism of oral vaccine against T1D was preliminarily discussed. The results showed that the disease-related indicators improved in immunized mice: fasting blood glucose improved, glucose tolerance and insulin secretion increased, pancreatic injury decreased, autoantibodies like GADA and IAA titers significantly decreased, and CD4 + T cell immune balance in mesenteric lymph node (MLN) and pancreatic lymph node (PLN) improved to some extent. The results suggest that oral vaccine Ca-Alg-GADIII has some therapeutic effect on STZ-induced T1D mice.
    • FullText(HTML)
    • References (19)
  • [1]
    . Front Immunol，2018，9：392.
    [2]
    Arneth B，Arneth R，Shams M. Metabolomics of type 1 and type 2 diabetes［J］. Int J Mol Sci，2019，20（10）：2467.
    [3]
    Rolandsson O，Hampe CS，Sharp SJ，et al. Autoimmunity plays a role in the onset of diabetes after 40 years of age［J］. Diabetologia，2020，63（2）：266-277.
    [4]
    Tisch R，Yang XD，Liblau RS，et al. Administering glutamic acid decarboxylase to NOD mice prevents diabetes［J］. J Autoimmun，1994，7（6）：845-850.
    [5]
    Yamamoto T，Yamato E，Tashiro F，et al. Development of autoimmune diabetes in glutamic acid decarboxylase 65 （GAD65） knockout NOD mice［J］. Diabetologia，2004，47（2）：221-224.
    [6]
    Casas R，Dietrich F，Barcenilla H，et al. Glutamic acid decarboxylase injection into lymph nodes：beta cell function and immune responses in recent onset type 1 diabetes patients［J］. Front Immunol，2020，11：564921.
    [7]
    Ludvigsson J. Autoantigen treatment in type 1 diabetes：unsolved questions on how to select autoantigen and administration route［J］. Int J Mol Sci，2020，21（5）：1598.
    [8]
    Wang HQ，Zhang HY，Yang J，et al. Preparation of a glutamate decarboxylase 65-related peptide fusion protein and its efficacy in the treatment of type 1 diabetes mellitus［J］. Pharm Biotechnol（药物生物技术），2009，16（4）：296-301.
    [9]
    Chen YL，Wu J，Wang JJ，et al. Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice［J］. Diabetologia，2018，61（6）：1384-1396.
    [10]
    Wu J，Liu XR，Yang X，et al. Hypoglycemic effect of Lactococcus lactis vaccine containing HSP65-6P277 on streptozotocin-induced type 1 diabetic mice［J］. J China Pharm Univ（中国药科大学学报），2014，45（1）：106-110.
    [11]
    Li M，Wang Y，Sun Y，et al. Mucosal vaccines：strategies and challenges［J］. Immunol Lett，2020，217：116-125.
    [12]
    Xu H，Hu FQ，Ying XY，et al. Preparation of insulin-loaded sodium alginate nanoparticles and its pharmacodynamics study on diabetic rats［J］. Chin Pharm J（中国药学杂志），2006，41（6）：434-437.
    [13]
    Yang JHM，Khatri L，Mickunas M，et al. Phenotypic analysis of human lymph nodes in subjects with new-onset type 1 diabetes and healthy individuals by flow cytometry［J］. Front Immunol，2019，10：2547.
    [14]
    Abdel-Moneim A，Bakery HH，Allam G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus［J］. Biomedecine Pharmacother，2018，101：287-292.
    [15]
    Zheng ZH，Zheng F. A complex auxiliary：IL-17/Th17 signaling during type 1 diabetes progression［J］. Mol Immunol，2019，105：16-31.
    [16]
    Tavira B，Barcenilla H，Wahlberg J，et al. Intralymphatic glutamic acid decarboxylase-alum administration induced Th2-like-specific immunomodulation in responder patients：a pilot clinical trial in type 1 diabetes［J］. J Diabetes Res，2018，2018：9391845.
    [17]
    Turner MS，Isse K，Fischer DK，et al. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes［J］. Diabetologia，2014，57（7）：1428-1436.
    [18]
    Bellemore SM，Nikoopour E，Schwartz JA，et al. Preventative role of interleukin-17 producing regulatory T helper type 17 （Treg 17） cells in type 1 diabetes in non-obese diabetic mice［J］. Clin Exp Immunol，2015，182（3）：261-269.
    [19]
    Clark M，Kroger CJ，Ke Q，et al. The role of T cell receptor signaling in the development of type 1 diabetes［J］. Front Immunol，2020，11：615371.
    • Related Articles

  • Related Articles

    [1]YU Juping, LIU Wei, YE Meng, TANG Dongyang, GAO Xiangdong. Effect of homologous overexpression of nucleoside diphosphate kinase on the yield and molecular weight of hyaluronic acid[J]. Journal of China Pharmaceutical University, 2022, 53(2): 232-238. DOI: 10.11665/j.issn.1000-5048.20220214
    [2]JIANG Liya, LUO Ping, DENG Shaorong, YE Hao, YU Yan, HAN Wei. Antitumor effect of recombinant mouse interleukin-33 in mice[J]. Journal of China Pharmaceutical University, 2020, 51(5): 584-590. DOI: 10.11665/j.issn.1000-5048.20200510
    [3]LI Chengfei, CHEN Ling, WU Xuri. Regio-selective glycosylation of mogroside IIIE by glycosyltransferase[J]. Journal of China Pharmaceutical University, 2019, 50(2): 222-229. DOI: 10.11665/j.issn.1000-5048.20190214
    [4]JIN Yue, WU Xuri, CHEN Yijun. Applications of glycosyltransferases in the improvement of druggability of natural products[J]. Journal of China Pharmaceutical University, 2017, 48(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20170504
    [5]XIA Yang, HU Lingling, CHEN Jiao, LU Wuguang, YAN Huaijiang, HUO Jiege, CAO Peng. Cloning and expression of recombinant BmkNaTx12, a new voltage-gated sodium channel from scorpion Buthus martensii Karsch[J]. Journal of China Pharmaceutical University, 2017, 48(2): 220-226. DOI: 10.11665/j.issn.1000-5048.20170214
    [6]WANG Yuanxi, CHEN Junsheng, SHAO Lei, LI Ji′an, LIN Huimin, CHEN Daijie. Heterologous expression and in vitro activity of vancomycin glycosyltransferase GtfE[J]. Journal of China Pharmaceutical University, 2013, 44(3): 272-276. DOI: 10.11665/j.issn.1000-5048.20130317
    [7]ZHAO Na, SUN Hong-bin. Poly(ADP-ribose) polymerase inhibitors and synthetic lethality[J]. Journal of China Pharmaceutical University, 2012, 43(2): 107-112.
    [8]LIN Yu-shuang, HONG Wen-rong. Construction of Streptomyces tenebrarius mutant with knockout of tobS1-C genes[J]. Journal of China Pharmaceutical University, 2012, 43(1): 92-96.
    [9]Construction of a high epidaunorubicin-producing strain by gene recombination[J]. Journal of China Pharmaceutical University, 2010, 41(3): 283-288.
    [10]PENG Chen, GE Hao, HE Shu-ying, GAO Xiang-dong. Molecular cloning，expression and identification of recombinant hyaluronan synthase from Pasteurella multocida[J]. Journal of China Pharmaceutical University, 2009, 40(6): 549-552.

  • Cited by

    Periodical cited type(1)

    1. 马小翔，马泽源，刘亚月，周龙建，和羿帆，张翼. 仿突变生物合成调控对土曲霉C23-3次生代谢产物的影响. 生物技术通报. 2024(08): 275-287 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365809

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return